Abeona Therapeutics Inc (0H7R.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 400,000 0 4,782,000 0
Cost of Revenue 100,000 815,000 0 722,000
Gross Profit 300,000 -815,000 2,391,000 -722,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 17,149,000 9,786,000 7,678,000 6,404,000
Operating Expenses 23,092,000 19,727,000 16,672,000 15,345,000
Operating Income -22,792,000 -19,727,000 -16,672,000 -15,345,000
Interest Expense 957,000 998,000 1,082,000 1,102,000
Income Before Tax 124,345,000 -12,029,000 -9,293,000 -30,269,000
Income Tax Expense 15,512,000 0 0 0
Net Income 108,833,000 -12,029,000 -9,293,000 -30,269,000
Per Share
EPS 2.07 -0.24 -0.23 -0.63
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 0 3,500,000 1,414,000
Cost of Revenue 2,907,000 1,605,000 4,577,000
Gross Profit -2,907,000 1,895,000 -3,163,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 29,851,000 19,004,000 13,129,000
Operating Expenses 61,304,000 49,030,000 42,094,000
Operating Income -64,211,000 -47,135,000 -45,257,000
Interest Expense 4,208,000 418,000 736,000
Income Before Tax -63,734,000 -54,188,000 -39,696,000
Income Tax Expense 0 0 3,782,000
Net Income -63,734,000 -54,188,000 -39,696,000
Per Share
EPS -1.55 -2.53 -5.05
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 23,357,000 14,473,000 14,555,000
Short Term Investments 74,363,000 37,753,000 37,932,000
Net Receivables 1,652,000 2,444,000 188,000
Inventory 0 0 0
Total Current Assets 100,853,000 55,737,000 53,099,000
Property Plant Equipment 7,982,000 7,988,000 11,072,000
Goodwill and Intangibles 0 0 0
Total Assets 108,931,000 64,002,000 64,214,000
Liabilities
Account Payables 3,441,000 1,858,000 1,811,000
Short Term Debt 6,749,000 998,000 1,773,000
Total Current Liabilities 16,587,000 13,422,000 7,779,000
Long Term Debt 16,299,000 4,402,000 0
Total Liabilities 64,900,000 49,176,000 37,453,000
Shareholders Equity
Retained Earnings -813,258,000 -749,524,000 -695,336,000
Total Shareholders Equity 44,031,000 14,826,000 26,761,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 23,357,000 14,473,000 14,555,000
Short Term Investments 74,363,000 37,753,000 37,932,000
Net Receivables 1,652,000 2,444,000 188,000
Inventory 0 0 0
Total Current Assets 100,853,000 55,737,000 53,099,000
Property Plant Equipment 7,982,000 7,988,000 11,072,000
Goodwill and Intangibles 0 0 0
Total Assets 108,931,000 64,002,000 64,214,000
Liabilities
Account Payables 3,441,000 1,858,000 1,811,000
Short Term Debt 6,749,000 998,000 1,773,000
Total Current Liabilities 16,587,000 13,422,000 7,779,000
Long Term Debt 16,299,000 4,402,000 0
Total Liabilities 64,900,000 49,176,000 37,453,000
Shareholders Equity
Retained Earnings -813,258,000 -749,524,000 -695,336,000
Total Shareholders Equity 44,031,000 14,826,000 26,761,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -63,734,000 -54,188,000 -39,696,000
Depreciation & Amortization 2,907,000 3,198,000 4,577,000
Stock Based Compensation 6,628,000 4,768,000 3,051,000
Change in Working Capital -4,383,000 -1,788,000 -5,892,000
Operating Cash Flow -56,015,000 -37,009,000 -43,483,000
Investing Activities
Capital Expenditure -2,446,000 -331,000 -130,000
Investments -2,446,000 -331,000 -130,000
Investing Cash Flow -39,240,000 208,000 -23,964,000
Financing Activities
Debt Repayment 20,000,000 0 0
Common Stock Issued/Repurchased 85,628,000 37,389,000 43,173,000
Dividends Paid 0 0 0
Financing Cash Flow 104,139,000 37,057,000 43,173,000
Summary
Free Cash Flow -58,461,000 -37,340,000 -43,613,000
Net Change in Cash 8,884,000 256,000 -23,374,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -63,734,000 -54,188,000 -39,696,000
Depreciation & Amortization 2,907,000 3,198,000 4,577,000
Stock Based Compensation 6,628,000 4,768,000 3,051,000
Change in Working Capital -4,383,000 -1,788,000 -5,892,000
Operating Cash Flow -56,015,000 -37,009,000 -43,483,000
Investing Activities
Capital Expenditure -2,446,000 -331,000 -130,000
Investments -2,446,000 -331,000 -130,000
Investing Cash Flow -39,240,000 208,000 -23,964,000
Financing Activities
Debt Repayment 20,000,000 0 0
Common Stock Issued/Repurchased 85,628,000 37,389,000 43,173,000
Dividends Paid 0 0 0
Financing Cash Flow 104,139,000 37,057,000 43,173,000
Summary
Free Cash Flow -58,461,000 -37,340,000 -43,613,000
Net Change in Cash 8,884,000 256,000 -23,374,000